Financial Contrast: PharmaCyte Biotech (OTCMKTS:PMCBD) and aTyr Pharma (NASDAQ:LIFE)
PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) and aTyr Pharma (NASDAQ:LIFE – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. Risk and Volatility PharmaCyte Biotech has a […]
More Stories
AT&T (NYSE:T) Stock Rating Upgraded by Royal Bank of Canada
Royal Bank of Canada upgraded shares of AT&T (NYSE:T – Free Report) from a sector perform rating to an outperform...
Truist Financial Lowers UnitedHealth Group (NYSE:UNH) Price Target to $610.00
UnitedHealth Group (NYSE:UNH – Free Report) had its price objective lowered by Truist Financial from $625.00 to $610.00 in a...
Aptiv (NYSE:APTV) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aptiv (NYSE:APTV – Free Report) in a research report report published on Monday. The...
BMO Capital Markets Upgrades Capri (NYSE:CPRI) to “Outperform”
BMO Capital Markets upgraded shares of Capri (NYSE:CPRI – Free Report) from a market perform rating to an outperform rating...
Insider Selling: B.P. Marsh & Partners PLC (LON:BPM) Insider Sells £138,937.50 in Stock
B.P. Marsh & Partners PLC (LON:BPM – Get Free Report) insider Francesca Chappell sold 18,750 shares of the stock in...
Bragg Gaming Group (NASDAQ:BRAG) Given New $5.00 Price Target at JMP Securities
Bragg Gaming Group (NASDAQ:BRAG – Free Report) had its price target lowered by JMP Securities from $6.00 to $5.00 in...